Literature DB >> 25573453

Myocardial collagen deposition and inflammatory cell infiltration in cats with pre-clinical hypertrophic cardiomyopathy.

K H Khor1, F E Campbell2, H Owen2, I A Shiels2, P C Mills3.   

Abstract

The histological features of feline hypertrophic cardiomyopathy (HCM) have been well documented, but there are no reports describing the histological features in mild pre-clinical disease, since cats are rarely screened for the disease in the early stages before clinical signs are apparent. Histological changes at the early stage of the disease in pre-clinical cats could contribute to an improved understanding of disease aetiology or progression. The aim of this study was to evaluate the histological features of HCM in the left ventricular (LV) myocardium of cats diagnosed with pre-clinical HCM. Clinically healthy cats with normal (n = 11) and pre-clinical HCM (n = 6) were identified on the basis of echocardiography; LV free wall dimensions (LVFWd) and/or interventricular septal wall (IVSd) dimensions during diastole of 6-7 mm were defined as HCM, while equivalent dimensions <5.5 mm were defined as normal. LV myocardial sections were assessed and collagen content and inflammatory cell infiltrates were quantified objectively. Multifocal areas of inflammatory cell infiltration, predominantly lymphocytes, were observed frequently in the left myocardium of cats with pre-clinical HCM. Tissue from cats with pre-clinical HCM also had a higher number of neutrophils and a greater collagen content than the myocardium of normal cats. The myocardium variably demonstrated other features characteristic of HCM, including arteriolar mural hypertrophy and interstitial fibrosis and, to a lesser extent, myocardial fibre disarray and cardiomyocyte hypertrophy. These results suggest that an inflammatory process could contribute to increased collagen content and the myocardial fibrosis known to be associated with HCM. Crown
Copyright © 2014. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Collagen; Feline; Hypertrophic cardiomyopathy; Inflammation; Myocardial fibre disarray

Mesh:

Substances:

Year:  2014        PMID: 25573453     DOI: 10.1016/j.tvjl.2014.11.018

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  8 in total

Review 1.  Human heart failure with preserved ejection versus feline cardiomyopathy: what can we learn from both veterinary and human medicine?

Authors:  Valentine Prat; Bertrand Rozec; Chantal Gauthier; Benjamin Lauzier
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

2.  Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy.

Authors:  Lu Fang; Andris H Ellims; Anna L Beale; Andrew J Taylor; Andrew Murphy; Anthony M Dart
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

3.  A Potential Link between the C5a Receptor 1 and the β1-Adrenoreceptor in the Mouse Heart.

Authors:  Kuan Hua Khor; Tyson A Moore; Ian A Shiels; Ristan M Greer; Thiruma V Arumugam; Paul C Mills
Journal:  PLoS One       Date:  2016-01-04       Impact factor: 3.240

4.  Biomarkers of Myocardial Fibrosis: Revealing the Natural History of Fibrogenesis in Fabry Disease Cardiomyopathy.

Authors:  Patrício Aguiar; Olga Azevedo; Rui Pinto; Jacira Marino; Carlos Cardoso; Nuno Sousa; Damião Cunha; Derralynn Hughes; José Luís Ducla Soares
Journal:  J Am Heart Assoc       Date:  2018-03-13       Impact factor: 5.501

5.  Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Cats With Hypertrophic Cardiomyopathy.

Authors:  Ryan C Fries; Saki Kadotani; Jonathan P Stack; Leah Kruckman; Gabrielle Wallace
Journal:  Front Vet Sci       Date:  2022-03-14

6.  Associations among echocardiography, cardiac biomarkers, insulin metabolism, morphology, and inflammation in cats with asymptomatic hypertrophic cardiomyopathy.

Authors:  Ingrid van Hoek; Hannah Hodgkiss-Geere; Elizabeth F Bode; Julie Hamilton-Elliott; Paul Mõtsküla; Valentina Palermo; Yolanda M Pereira; Geoff J Culshaw; Anna Ivanova; Jo Dukes-McEwan
Journal:  J Vet Intern Med       Date:  2020-02-11       Impact factor: 3.333

7.  The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy.

Authors:  Mark D Kittleson; Etienne Côté
Journal:  J Feline Med Surg       Date:  2021-11       Impact factor: 2.015

8.  Feline hypertrophic cardiomyopathy: reduced microvascular density and involvement of CD34+ interstitial cells.

Authors:  Josep M Monné Rodríguez; Sonja Fonfara; Udo Hetzel; Anja Kipar
Journal:  Vet Pathol       Date:  2021-12-27       Impact factor: 2.221

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.